Academic Pediatric Infectious Disease
Academic Pediatric Infectious Disease
批准号:
10406156
负责人:
KEVIN B URDAHL
金额:
$29.68万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-07-01 至 2023-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The objective of our University of Washington’s (UW) Pediatric Infectious Diseases (PID) Training Program
(TP) is to train future leaders in research on infectious diseases of children. Our TP (1) recruits experienced
and committed pediatricians; (2) trains them in basic and novel molecular, genomic, proteomic, bioinformatic,
and epidemiologic methods, and (3) mentors them to develop and lead an independent research program.
We request the renewal of T32 support to train four pediatricians in research annually. Initially, each fellow
engages in 12 months of clinical training (for PID certification), supported by Seattle Children's Hospital (SCH).
Subsequently, the T32 will support 2 years of mentored research by Training Faculty (TF) who are leaders in
their areas of research and excel at mentorship. Trainees and TF are encouraged to tackle projects that will
contribute novel and critical insights into understanding and treating pediatric infectious diseases and generate
preliminary data for a K, R, or other award. In addition, fellows receive didactic and hands-on education in the
federal regulations governing research with humans and/or animals, grant and manuscript preparation, and
strategies to succeed in academia. Our curriculum includes a structured timeline to transition to “K”-series NIH
awards, and if needed, our department extends support to assist trainees in this transition.
Our NIH T32-supported UW-PID-FP has trained 94 fellows since 1981, with a consistent record of developing
research leaders in Maternal-Child Health (Figure 1). During the past 15 years, 34 fellows have successfully
completed our TP, 1 transferred to a different TP, and 9 are current fellows. As of May 2017, of the 34 TP
graduates from the past 15 years, 18 (53%) have been awarded Ks. Of the graduates completing our TP more
than 5 years ago (and therefore at the stage one would progress to NIH R-level funding), 11/26 (42%) have
received Rs. Biomedical research continues to be a primary focus of 26/34 (76%) graduates from the last 15
years: 17 lead academic labs (PIs of R, K or foundation grants), 2 are academic research scientists, 4 are lead
researchers within government institutions with intramural funds, 1 is an industry researcher, and 2 are
university biology professors teaching undergraduates and performing research. The remaining 8/34 (24%)
include: 2 clinician educators at academic hospitals where they participate in research, and 6 clinical
specialists in infectious diseases. We have 9 current fellows and 1 new fellow entering in July 2017; 8 of these
have submitted ≥1 individual applications for K and/or foundation grants; 4 received awards, and 6 have
pending applications. Among our current fellows and recent graduates (N=43) from the past 15 years, 6 (14%)
are under-represented-minorities (URM) in health sciences. In 2017, two fellows will complete their 3rd year of
fellowship and both will continue as 4th-year Senior Fellows/Instructors with funding by our department or their
pending K and/or other grant applications; 2 others will complete their 4th-year of fellowship, one joining
Georgetown University as an Assistant Professor and the other currently deciding between 3 university offers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mtb strain-dependent mechanisms of pathogenesis in mouse models
-
批准号:10653921
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2021
-
负责人:KEVIN B URDAHL
-
依托单位:
Mtb strain-dependent mechanisms of pathogenesis in mouse models
-
批准号:10271174
-
项目类别:
-
资助金额:$59.08万
-
财政年份:2021
-
负责人:KEVIN B URDAHL
-
依托单位:
Mtb strain-dependent mechanisms of pathogenesis in mouse models
-
批准号:10459541
-
项目类别:
-
资助金额:$53.19万
-
财政年份:2021
-
负责人:KEVIN B URDAHL
-
依托单位:
Immune-mediated elimination of antigen-specific Tregs during infection and cancer
-
批准号:8692388
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2014
-
负责人:KEVIN B URDAHL
-
依托单位:
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
-
批准号:8640882
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:KEVIN B URDAHL
-
依托单位:
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses
-
批准号:8830198
-
项目类别:
-
资助金额:$55.27万
-
财政年份:2012
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:8091459
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:7654539
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:7880126
-
项目类别:
-
资助金额:$12.27万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:8121114
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:8632658
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
T regulatory cells and immunity in tuberculosis
-
批准号:8241620
-
项目类别:
-
资助金额:$48.15万
-
财政年份:2009
-
负责人:KEVIN B URDAHL
-
依托单位:
MHC class 1 molecules in immunity against tuberculosis
-
批准号:6674991
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2003
-
负责人:KEVIN B URDAHL
-
依托单位:
MHC class 1 molecules in immunity against tuberculosis
-
批准号:6876176
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2003
-
负责人:KEVIN B URDAHL
-
依托单位:
MHC class 1 molecules in immunity against tuberculosis
-
批准号:6761963
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2003
-
负责人:KEVIN B URDAHL
-
依托单位:
Academic Pediatric Infectious Disease
-
批准号:9926919
-
项目类别:
-
资助金额:$28.34万
-
财政年份:1981
-
负责人:KEVIN B URDAHL
-
依托单位:
Academic Pediatric Infectious Disease
-
批准号:10626406
-
项目类别:
-
资助金额:$35.62万
-
财政年份:1981
-
负责人:KEVIN B URDAHL
-
依托单位:
海外基金